Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Runt-Related Transcription Factor 1 (RUNX1) (Middle Region) Peptide

RUNX1 Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN5672381

Aperçu rapide pour Runt-Related Transcription Factor 1 (RUNX1) (Middle Region) Peptide (ABIN5672381)

Antigène

RUNX1 (Runt-Related Transcription Factor 1 (RUNX1))

Origine

Humain

Source

  • 9
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Séquence

    FTNPPQVATY HRAIKITVDG PREPRRHRQK LDDQTKPGSL SFSERLSELE

    Attributs du produit

    This is a synthetic peptide designed for use in combination with anti- RUNX1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène

    RUNX1 (Runt-Related Transcription Factor 1 (RUNX1))

    Sujet

    Core binding factor (CBF) is a heterodimeric transcription factor that binds to the core element of many enhancers and promoters. The protein encoded by this gene represents the alpha subunit of CBF and is thought to be involved in the development of normal hematopoiesis. Chromosomal translocations involving this gene are well-documented and have been associated with several types of leukemia. Three transcript variants encoding different isoforms have been found for this gene.

    Alias Symbols: AML1, CBFA2, EVI-1, AMLCR1, PEBP2aB, CBF2alpha, AML1-EVI-1, PEBP2alpha

    Protein Size: 250

    ID gène

    861

    NCBI Accession

    NM_001001890, NP_001001890
Vous êtes ici:
Chat with us!